Portfolio (Quarterly)
Guide ↗
GENERAL ATLANTIC, L.P.
· CIK 0001017645| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | DLO | DLOCAL | Technology | 46,656,695.0 | $605.1M | 28.17% | — | — | $12.97 | -5.6% |
| 2 | CHYM | CHIME | Financial Services | 21,259,683.0 | $398.2M | 18.53% | — | — | $18.73 | -3.3% |
| 3 | XP | XP, INC | Financial Services | 20,566,133.0 | $391.6M | 18.23% | -2.1M | -9.4% | $19.04 | -7.1% |
| 4 | ALKT | ALKAMI | Technology | 15,337,495.0 | $240.3M | 11.19% | +3.3M | +27.9% | $15.67 | +7.7% |
| 5 | PHVS | PHARVARIS | Healthcare | 8,031,252.0 | $226.9M | 10.56% | — | — | $28.25 | +4.2% |
| 6 | EWCZ | EUROPEAN WAX CENTER | Consumer Defensive | 13,110,492.0 | $75.8M | 3.53% | — | — | $5.78 | +0.7% |
| 7 | RVMD | REVOLUTION MEDICINES | Healthcare | 707,791.0 | $68.8M | 3.20% | -2.1M | -74.8% | $97.25 | +54.6% |
| 8 | NRIX | NURIX THERAPEUTICS | Healthcare | 4,101,865.0 | $63.6M | 2.96% | -795K | -16.2% | $15.50 | +13.1% |
| 9 | CNTA | CENTESSA PHARMACEUTICALS | Healthcare | 1,354,830.0 | $53.8M | 2.50% | -4.8M | -77.8% | $39.72 | +0.2% |
| 10 | RSKD | RISKIFIED | Technology | 5,324,998.0 | $20.9M | 0.97% | — | — | $3.92 | +24.7% |
| 11 | — | GROVE COLLABORATIVE | — | 2,474,859.0 | $3.2M | 0.15% | — | — | $1.28 | — |
| 12 | — | WEBULL | — | 50,816.0 | $244K | 0.01% | — | — | $4.80 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Technology
40.4%
Financial Services
36.8%
Healthcare
19.3%
Consumer Defensive
3.5%